Institut Clinique de la Souris

Institut Clinique de la Souris
Name	Institut Clinique de la Souris
Established	2005
Type	Research center
Location	Illkirch-Graffenstaden, Bas-Rhin, Grand Est, France

Institut Clinique de la Souris is a biomedical research facility specializing in mammalian genetics and phenotyping, located near Strasbourg in the Grand Est region of France. The institute supports preclinical model development and high-throughput phenotyping to advance studies in genetics, metabolism, neuroscience, immunology and developmental biology. It serves academic and industrial partners across Europe and worldwide, contributing to translational efforts linking model organisms to human disease.

History

The institute was founded in the context of European biomedical networks that include European Molecular Biology Laboratory, Institut Pasteur, Max Planck Society, European Research Council, CNRS and INSERM, reflecting collaborative trends seen with Wellcome Trust, Howard Hughes Medical Institute, National Institutes of Health, Medical Research Council, German Research Foundation and Horizon 2020. Early programs were influenced by initiatives such as the Human Genome Project, International Knockout Mouse Consortium, European Mouse Mutant Archive, Mouse Genome Informatics, Europhenome and International Mouse Phenotyping Consortium. Leadership and scientific staff have engaged with groups like European Bioinformatics Institute, Karolinska Institutet, University of Oxford, University of Cambridge, Sorbonne University, École Polytechnique Fédérale de Lausanne, University of Munich, University of Paris, Imperial College London and University of California, San Francisco. The institute’s development paralleled advances driven by technologies from CRISPR-Cas9, zinc finger nucleases, TALENs, next-generation sequencing, single-cell RNA sequencing and imaging mass cytometry.

Mission and Research Focus

The mission emphasizes generating, characterizing and distributing genetically defined mouse models to address questions at the intersection of human genetics, neuroscience, immunology, metabolism and oncology. Research directions align with priorities of agencies such as European Research Council, Agence Nationale de la Recherche, National Institutes of Health, Wellcome Trust, Bill & Melinda Gates Foundation, European Commission and Horizon Europe. The institute supports studies related to disorders investigated at institutions like Institut Pasteur, Great Ormond Street Hospital, Mayo Clinic, Cleveland Clinic, Johns Hopkins University, Karolinska Institutet and Massachusetts General Hospital. Scientific themes connect to consortia including International Mouse Phenotyping Consortium, Euro-BioImaging, ELIXIR, Global Alliance for Genomics and Health and Human Cell Atlas.

Facilities and Services

Facilities include high-throughput phenotyping pipelines, behavioral platforms, metabolic cages, imaging suites and colony management supported by core technologies such as magnetic resonance imaging, positron emission tomography, micro-computed tomography, optical coherence tomography and two-photon microscopy. Services offered mirror those available at centers like EMBL, Wellcome Sanger Institute, The Francis Crick Institute, Broad Institute, Dana-Farber Cancer Institute, Roche Innovation Center and Novartis Institutes for BioMedical Research: model generation, cryopreservation, genotyping, histopathology, flow cytometry, immunohistochemistry and bioinformatics. Bioinformatics support integrates resources such as Ensembl, GenBank, UniProt, GEO, ArrayExpress and Mouse Genome Informatics to enable data sharing across platforms used by European Bioinformatics Institute and ELIXIR nodes.

Major Projects and Contributions

The institute has contributed mouse models and phenotypic data to international efforts including the International Mouse Phenotyping Consortium, International Knockout Mouse Consortium, European Mouse Mutant Archive and projects linked to the Human Phenotype Ontology, OMIM, ClinVar and GTEx. Contributions intersect research carried out at centers such as Harvard Medical School, Stanford University School of Medicine, University College London, Karolinska Institutet, ETH Zurich and CNRS laboratories. The institute’s work has supported studies on pathways relevant to Alzheimer's disease, Parkinson's disease, type 2 diabetes mellitus, obesity, autoimmune diseases, cancer and cardiovascular disease, informing translational programs at Sanofi, AstraZeneca, Pfizer, Roche, Novartis and GlaxoSmithKline.

Collaborations and Partnerships

Collaborative relationships span universities, public research organizations and industry partners including engagements with Université de Strasbourg, CNRS, INSERM, Université de Paris, Institut Pasteur, EMBL, Wellcome Trust Sanger Institute, Broad Institute, Sanofi, Roche, Novartis, AstraZeneca and Pfizer. International partnerships extend to University of Cambridge, Imperial College London, Karolinska Institutet, ETH Zurich, Max Planck Society, Johns Hopkins University, Harvard Medical School and Massachusetts Institute of Technology. The institute participates in European consortia funded by Horizon 2020, Horizon Europe and national agencies like Agence Nationale de la Recherche and interfaces with repositories such as the European Mouse Mutant Archive and metadata initiatives exemplified by ELIXIR and Europhenome.

Organization and Funding

Administratively the institute operates within frameworks similar to those of CNRS and INSERM institutes, with governance models engaging academic partners such as Université de Strasbourg, regional authorities in Grand Est and funders like Agence Nationale de la Recherche, European Research Council, European Commission, Wellcome Trust, European Investment Bank and private industry collaborators including Sanofi and Roche. Project funding mixes public grants, competitive awards and service contracts analogous to arrangements seen at Institut Pasteur, EMBL, Max Planck Institute for Molecular Genetics, Wellcome Sanger Institute and Broad Institute.

Category:Research institutes in France Category:Biomedical research centers